speb/financial-data huggingface dataset:
IVF cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
IVF balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 3172441.00
IVF balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 3172441.00
IVF balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 163115.00
IVF balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 163115.00
IVF balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 163115.00
IVF balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 163115.00
IVF balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 1220528.00
IVF balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 1220528.00
IVF income_statement (annual, 2024-12-31) — Normalized EBITDA: -5187402.00
IVF income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -3213867.00
IVF income_statement (annual, 2024-12-31) — Normalized Income: -7378446.63
IVF income_statement (quarterly, 2024-12-31) — Normalized Income: -3623493.00
IVF cash_flow (annual, 2024-12-31) — Operating Cash Flow: -2974400.00
IVF cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -617379.00
IVF cash_flow (annual, 2024-12-31) — Operating Gains Losses: 543109.00
IVF cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -18467.00
IVF income_statement (annual, 2024-12-31) — Operating Income: -6116050.00
IVF income_statement (quarterly, 2024-12-31) — Operating Income: -3464144.00
IVF income_statement (annual, 2024-12-31) — Operating Revenue: 6532000.00
IVF income_statement (quarterly, 2024-12-31) — Operating Revenue: 1685966.00
IVF balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 3108.00
IVF balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 3108.00
IVF balance_sheet (annual, 2024-12-31) — Other Current Assets: 180853.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 180853.00
IVF balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 5173293.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 5173293.00
IVF balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 4704521.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 4704521.00
IVF income_statement (annual, 2024-12-31) — Other Income Expense: -448558.00
IVF income_statement (quarterly, 2024-12-31) — Other Income Expense: 18467.00
IVF balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 3532931.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 3532931.00
IVF cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1206324.00
IVF cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 630216.00
IVF balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 32484707.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 32484707.00
IVF balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 479768.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 479768.00
IVF balance_sheet (annual, 2024-12-31) — Other Payable: 2500000.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Payable: 2500000.00
IVF balance_sheet (annual, 2024-12-31) — Other Properties: 2109278.00
IVF balance_sheet (quarterly, 2024-12-31) — Other Properties: 2109278.00
IVF income_statement (annual, 2024-12-31) — Other Special Charges: -54060.00
IVF income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
IVF income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 250635.00
IVF balance_sheet (annual, 2024-12-31) — Payables: 5613660.00
IVF balance_sheet (quarterly, 2024-12-31) — Payables: 5613660.00
IVF balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 5613660.00
IVF balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 5613660.00
IVF balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 713483.00
IVF balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 713483.00
IVF balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 7457000.00
IVF balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 7457000.00
IVF balance_sheet (annual, 2024-12-31) — Preferred Stock: 30375000.00
IVF balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 30375000.00
IVF balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 30375000.00
IVF balance_sheet (quarterly, 2024-12-31) — Preferred Stock Equity: 30375000.00
IVF cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 1643904.00
IVF cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
IVF cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
IVF income_statement (annual, 2024-12-31) — Pretax Income: -7599751.00
IVF income_statement (quarterly, 2024-12-31) — Pretax Income: -3677501.00
IVF cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 900611.00
IVF cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
IVF balance_sheet (annual, 2024-12-31) — Properties: 0.00
IVF balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
IVF cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
IVF cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
IVF cash_flow (annual, 2024-12-31) — Purchase Of PPE: -183703.00
IVF cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -78874.00
IVF balance_sheet (annual, 2024-12-31) — Raw Materials: 53537.00
IVF balance_sheet (quarterly, 2024-12-31) — Raw Materials: 53537.00
IVF balance_sheet (annual, 2024-12-31) — Receivables: 113108.00
IVF balance_sheet (quarterly, 2024-12-31) — Receivables: 113108.00
IVF income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3657766.00
IVF income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 957419.00
IVF income_statement (annual, 2024-12-31) — Reconciled Depreciation: 919603.00
IVF income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 231810.00
IVF cash_flow (annual, 2024-12-31) — Repayment Of Debt: -934419.00
IVF cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -155950.00
IVF cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
IVF income_statement (annual, 2024-12-31) — Research And Development: 4880.00
IVF income_statement (quarterly, 2024-12-31) — Research And Development: 484780.00
IVF balance_sheet (annual, 2024-12-31) — Retained Earnings: -67327733.00
IVF balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -67327733.00
IVF cash_flow (annual, 2024-12-31) — Sale Of Business: 472008.00
IVF cash_flow (annual, 2024-12-31) — Sale Of PPE: 75590.00
IVF cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
IVF income_statement (annual, 2024-12-31) — Selling General And Administration: 8065801.00
IVF income_statement (quarterly, 2024-12-31) — Selling General And Administration: 3476101.00
IVF balance_sheet (annual, 2024-12-31) — Share Issued: 3108.00
IVF balance_sheet (quarterly, 2024-12-31) — Share Issued: 3108.00
IVF cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
IVF income_statement (annual, 2024-12-31) — Special Income Charges: -457603.00
IVF income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
IVF cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1589646.00
IVF cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 169367.00
IVF balance_sheet (annual, 2024-12-31) — Stockholders Equity: 12584358.00
IVF balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 12584358.00
IVF balance_sheet (annual, 2024-12-31) — Tangible Book Value: -27202559.00
IVF balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: -27202559.00
IVF income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -96096.63
IVF income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IVF income_statement (annual, 2024-12-31) — Tax Provision: 140202.00
IVF income_statement (quarterly, 2024-12-31) — Tax Provision: -54008.00
IVF income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
IVF income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.01
IVF balance_sheet (annual, 2024-12-31) — Total Assets: 46077014.00
IVF balance_sheet (quarterly, 2024-12-31) — Total Assets: 46077014.00
IVF balance_sheet (annual, 2024-12-31) — Total Capitalization: 13713071.00
IVF balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 13713071.00
IVF balance_sheet (annual, 2024-12-31) — Total Debt: 8758750.00
IVF balance_sheet (quarterly, 2024-12-31) — Total Debt: 8758750.00
IVF balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 12584358.00
IVF balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 12584358.00
IVF income_statement (annual, 2024-12-31) — Total Expenses: 12648050.00
IVF income_statement (quarterly, 2024-12-31) — Total Expenses: 5150110.00
IVF balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 33492656.00
IVF balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 33492656.00
IVF balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 45077456.00
IVF balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 45077456.00
IVF balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 15624208.00
IVF balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 15624208.00
IVF income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -6627713.00
IVF income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -3975807.00
IVF income_statement (annual, 2024-12-31) — Total Unusual Items: -457603.00
IVF income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
IVF income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -457603.00
IVF income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IVF balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 5000000.00
IVF balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 5000000.00
IVF balance_sheet (annual, 2024-12-31) — Working Capital: -16611890.00
IVF balance_sheet (quarterly, 2024-12-31) — Working Capital: -16611890.00
IVF income_statement (annual, 2024-12-31) — Write Off: 0.00
IVF income_statement (quarterly, 2025-03-31) — +Operating Expense: 1791784.00
IVF income_statement (quarterly, 2025-03-31) — +Total Revenue: 1637185.00
IVF balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4785477.00
IVF balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 173614.00
IVF balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -365783.00
IVF balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 57833740.00
IVF cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 204375.00
IVF cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 204375.00
IVF cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 14645069.00
IVF income_statement (quarterly, 2025-03-31) — Basic Average Shares: 5010.00
IVF income_statement (quarterly, 2025-03-31) — Basic EPS: -3473.93
IVF cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 741396.00
IVF cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -14650.00
IVF balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2372486.00
IVF balance_sheet (quarterly, 2025-03-31) — Capital Stock: 30375074.00
IVF balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 840407.00
IVF balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 840407.00
IVF balance_sheet (quarterly, 2025-03-31) — Cash Financial: 840407.00
IVF cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3659195.00
IVF cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -14650.00
IVF cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3545534.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -934839.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -250329.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Interest Payable: 6360.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Inventory: 3306.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 4884.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 122971.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Payable: -934839.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1185168.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -156353.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1267.00
IVF cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1209093.00
IVF cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1267.00
IVF cash_flow (quarterly, 2025-03-31) — Changes In Cash: 99011.00
IVF balance_sheet (quarterly, 2025-03-31) — Common Stock: 74.00
IVF balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -27039635.00
IVF cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 8747902.00
IVF income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1044929.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Assets: 1569122.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 247750.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Debt: 5378912.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 5626662.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 725330.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 725330.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 18718955.00
IVF balance_sheet (quarterly, 2025-03-31) — Current Notes Payable: 880000.00
IVF cash_flow (quarterly, 2025-03-31) — Depreciation: 30087.00
IVF cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 234462.00
IVF income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 234462.00
IVF cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 234462.00
IVF income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 234462.00
IVF income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 5010.00
IVF income_statement (quarterly, 2025-03-31) — Diluted EPS: -3473.93
IVF income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -17403586.00
IVF income_statement (quarterly, 2025-03-31) — EBIT: -1184432.00
IVF income_statement (quarterly, 2025-03-31) — EBITDA: -949970.00
IVF income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 15096.00
IVF cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -15096.00
IVF cash_flow (quarterly, 2025-03-31) — End Cash Position: 840407.00
IVF cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3659195.00
IVF balance_sheet (quarterly, 2025-03-31) — Finished Goods: 163798.00
IVF cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3560184.00
IVF income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 0.00
IVF balance_sheet (quarterly, 2025-03-31) — Goodwill: 8890624.00
IVF balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 26790180.00
IVF balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3039736.00
IVF income_statement (quarterly, 2025-03-31) — Gross Profit: 592256.00
IVF income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 14645069.00
IVF income_statement (quarterly, 2025-03-31) — Interest Expense: 307839.00
IVF income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 307839.00
IVF cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 169042.00
IVF balance_sheet (quarterly, 2025-03-31) — Inventory: 216458.00
IVF balance_sheet (quarterly, 2025-03-31) — Invested Capital: -20574591.00
IVF cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -14650.00
IVF balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 710855.00
IVF balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 710855.00
IVF cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 8747902.00
IVF cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
IVF balance_sheet (quarterly, 2025-03-31) — Leases: 96817.00
IVF balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2124736.00
IVF balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1086132.00
IVF balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 3210868.00
IVF cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
IVF cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1088795.00
IVF balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 710855.00
IVF balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 89904.00
IVF cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
IVF cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 8747902.00
IVF balance_sheet (quarterly, 2025-03-31) — Net Debt: 5624637.00
IVF income_statement (quarterly, 2025-03-31) — Net Income: -17403586.00
IVF income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -17403586.00
IVF income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1492271.00
IVF income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -15911315.00
IVF income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -17403586.00
IVF income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1492271.00
IVF cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -17403586.00
IVF income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -17403586.00
IVF income_statement (quarterly, 2025-03-31) — Net Interest Income: -307839.00
IVF cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1088795.00
IVF cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -1088795.00
IVF income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -307839.00
IVF balance_sheet (quarterly, 2025-03-31) — Net PPE: 2673953.00
IVF cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -14650.00
IVF cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: -4000000.00
IVF balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -23454815.00
IVF income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -949970.00
IVF income_statement (quarterly, 2025-03-31) — Normalized Income: -1492271.00
IVF cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3545534.00
IVF cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -15096.00
IVF income_statement (quarterly, 2025-03-31) — Operating Income: -1199528.00
IVF income_statement (quarterly, 2025-03-31) — Operating Revenue: 1637185.00
IVF balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 6218.00
IVF balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 338643.00
IVF balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 4498912.00
IVF balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 715245.00
IVF income_statement (quarterly, 2025-03-31) — Other Income Expense: 15096.00
IVF balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 17899556.00
IVF cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 132055.00
IVF balance_sheet (quarterly, 2025-03-31) — Other Payable: 5000000.00
IVF balance_sheet (quarterly, 2025-03-31) — Other Properties: 2853015.00
IVF balance_sheet (quarterly, 2025-03-31) — Payables: 9785477.00
IVF balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 9785477.00
IVF balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1866241.00
IVF balance_sheet (quarterly, 2025-03-31) — Preferred Securities Outside Stock Equity: 3978922.00
IVF balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 30375000.00
IVF balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 30375000.00
IVF cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 0.00
IVF cash_flow (quarterly, 2025-03-31) — Preferred Stock Payments: -4000000.00
IVF income_statement (quarterly, 2025-03-31) — Pretax Income: -1492271.00
IVF cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 88.00
IVF balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
IVF cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
IVF cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -14650.00
IVF balance_sheet (quarterly, 2025-03-31) — Raw Materials: 52660.00
IVF balance_sheet (quarterly, 2025-03-31) — Receivables: 173614.00
IVF income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1044929.00
IVF income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 234462.00
IVF cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1088795.00
IVF cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -4000000.00
IVF income_statement (quarterly, 2025-03-31) — Research And Development: 265663.00
IVF balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -84873449.00
IVF cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
IVF income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1557322.00
IVF balance_sheet (quarterly, 2025-03-31) — Share Issued: 6218.00
IVF income_statement (quarterly, 2025-03-31) — Special Income Charges: -14645069.00
IVF cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 70655.00
IVF balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3335365.00
IVF balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -53829815.00
IVF income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IVF income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
IVF income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
IVF balance_sheet (quarterly, 2025-03-31) — Total Assets: 31744110.00
IVF balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4421497.00
IVF balance_sheet (quarterly, 2025-03-31) — Total Debt: 8837530.00
IVF balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3335365.00
IVF income_statement (quarterly, 2025-03-31) — Total Expenses: 2836713.00
IVF balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 28408745.00
IVF balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 30174988.00
IVF balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9689790.00
IVF income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1199528.00
IVF income_statement (quarterly, 2025-03-31) — Total Unusual Items: -14645069.00
IVF income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -14645069.00
IVF balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 2500000.00
IVF balance_sheet (quarterly, 2025-03-31) — Working Capital: -17149833.00
IVF income_statement (quarterly, 2025-03-31) — Write Off: 14645069.00
IVF income_statement (quarterly, 2025-06-30) — +Operating Expense: 2362786.00
IVF income_statement (quarterly, 2025-06-30) — +Total Revenue: 1863654.00
IVF balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2226600.00
IVF balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 242255.00
IVF balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -397160.00
IVF balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 82712709.00
IVF cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 138358.00
IVF cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 138358.00
IVF cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1397353.00
IVF balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
IVF income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3311.00
IVF income_statement (quarterly, 2025-06-30) — Basic EPS: -1596.00
IVF cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 840407.00
IVF cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -8877.00
IVF balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2314683.00
IVF balance_sheet (quarterly, 2025-06-30) — Capital Stock: 10122005.00
IVF balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 549181.00
IVF balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 549181.00
IVF balance_sheet (quarterly, 2025-06-30) — Cash Financial: 549181.00
IVF cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1441841.00
IVF cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -15446.00
IVF cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1717621.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 245732.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 581716.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Interest Payable: 108547.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Inventory: 3847.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -995477.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 109520.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Payable: 245732.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 827448.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -118280.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Receivables: -68641.00
IVF cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -241583.00
IVF cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -68641.00
IVF cash_flow (quarterly, 2025-06-30) — Changes In Cash: -291226.00
IVF balance_sheet (quarterly, 2025-06-30) — Common Stock: 83.00
IVF balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -7490449.00
IVF cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
IVF income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1093603.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Assets: 1399353.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 256620.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Debt: 3768947.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 4025567.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 834850.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 834850.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 12463211.00
IVF balance_sheet (quarterly, 2025-06-30) — Current Notes Payable: 880000.00
IVF cash_flow (quarterly, 2025-06-30) — Depreciation: 31378.00
IVF cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 169736.00
IVF income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 169737.00
IVF cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 169736.00
IVF income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 169737.00
IVF income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3311.00
IVF income_statement (quarterly, 2025-06-30) — Diluted EPS: -1596.00
IVF income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5284858.00
IVF income_statement (quarterly, 2025-06-30) — EBIT: -2987769.00
IVF income_statement (quarterly, 2025-06-30) — EBITDA: -2818032.00
IVF income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -19911.00
IVF cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 19911.00
IVF cash_flow (quarterly, 2025-06-30) — End Cash Position: 549181.00
IVF cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1441841.00
IVF balance_sheet (quarterly, 2025-06-30) — Finished Goods: 161110.00
IVF cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1726498.00
IVF income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 0.00
IVF balance_sheet (quarterly, 2025-06-30) — Goodwill: 5878986.00
IVF balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 7414831.00
IVF balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2986286.00
IVF income_statement (quarterly, 2025-06-30) — Gross Profit: 770051.00
IVF income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 1397353.00
IVF income_statement (quarterly, 2025-06-30) — Interest Expense: 221325.00
IVF income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 221325.00
IVF cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 114306.00
IVF balance_sheet (quarterly, 2025-06-30) — Inventory: 212611.00
IVF balance_sheet (quarterly, 2025-06-30) — Invested Capital: -2680010.00
IVF cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -15446.00
IVF balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 3112754.00
IVF balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 645944.00
IVF balance_sheet (quarterly, 2025-06-30) — Investmentsin Subsidiariesat Cost: 2466810.00
IVF cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 500000.00
IVF cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
IVF balance_sheet (quarterly, 2025-06-30) — Leases: 96817.00
IVF balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2058063.00
IVF balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1041492.00
IVF balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 3099555.00
IVF balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 3112754.00
IVF balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 89904.00
IVF cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -6569.00
IVF cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
IVF balance_sheet (quarterly, 2025-06-30) — Net Debt: 4261258.00
IVF income_statement (quarterly, 2025-06-30) — Net Income: -5284858.00
IVF income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5284858.00
IVF income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -3209094.00
IVF income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -2075764.00
IVF income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5284858.00
IVF income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -3209094.00
IVF cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -5284858.00
IVF income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -5284858.00
IVF income_statement (quarterly, 2025-06-30) — Net Interest Income: -221325.00
IVF cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -82708.00
IVF income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -221325.00
IVF balance_sheet (quarterly, 2025-06-30) — Net PPE: 2589126.00
IVF cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -8877.00
IVF cash_flow (quarterly, 2025-06-30) — Net Preferred Stock Issuance: 500000.00
IVF balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -4783358.00
IVF balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 4803175.00
IVF income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1442909.00
IVF income_statement (quarterly, 2025-06-30) — Normalized Income: -1833971.00
IVF cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1717621.00
IVF cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2246698.00
IVF income_statement (quarterly, 2025-06-30) — Operating Income: -1592735.00
IVF income_statement (quarterly, 2025-06-30) — Operating Revenue: 1863654.00
IVF balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 20702.00
IVF balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 395306.00
IVF balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2888947.00
IVF balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 10500.00
IVF income_statement (quarterly, 2025-06-30) — Other Income Expense: -1395034.00
IVF balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1535845.00
IVF cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -685647.00
IVF balance_sheet (quarterly, 2025-06-30) — Other Payable: 5000000.00
IVF balance_sheet (quarterly, 2025-06-30) — Other Properties: 2799565.00
IVF income_statement (quarterly, 2025-06-30) — Other Special Charges: -22230.00
IVF balance_sheet (quarterly, 2025-06-30) — Payables: 7226600.00
IVF balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 7226600.00
IVF balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 365694.00
IVF balance_sheet (quarterly, 2025-06-30) — Preferred Securities Outside Stock Equity: 0.00
IVF balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 10121922.00
IVF balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 10121922.00
IVF cash_flow (quarterly, 2025-06-30) — Preferred Stock Issuance: 500000.00
IVF cash_flow (quarterly, 2025-06-30) — Preferred Stock Payments: 0.00
IVF income_statement (quarterly, 2025-06-30) — Pretax Income: -3209094.00
IVF cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 1024549.00
IVF balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
IVF cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -6569.00
IVF cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -8877.00
IVF balance_sheet (quarterly, 2025-06-30) — Raw Materials: 51501.00
IVF balance_sheet (quarterly, 2025-06-30) — Receivables: 242255.00
IVF income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1093604.00
IVF income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 169736.00
IVF cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -82708.00
IVF cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
IVF income_statement (quarterly, 2025-06-30) — Research And Development: 0.00
IVF balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -90203241.00
IVF cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
IVF income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2193049.00
IVF balance_sheet (quarterly, 2025-06-30) — Share Issued: 20702.00
IVF income_statement (quarterly, 2025-06-30) — Special Income Charges: -1375123.00
IVF cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 680680.00
IVF balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2631473.00
IVF balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -14905280.00
IVF income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IVF income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
IVF income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
IVF balance_sheet (quarterly, 2025-06-30) — Total Assets: 19319239.00
IVF balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3672965.00
IVF balance_sheet (quarterly, 2025-06-30) — Total Debt: 7125122.00
IVF balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2631473.00
IVF income_statement (quarterly, 2025-06-30) — Total Expenses: 3456389.00
IVF balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 16687766.00
IVF balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 17919886.00
IVF balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 4224555.00
IVF income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -2990088.00
IVF income_statement (quarterly, 2025-06-30) — Total Unusual Items: -1375123.00
IVF income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -1375123.00
IVF balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 1125000.00
IVF balance_sheet (quarterly, 2025-06-30) — Working Capital: -11063858.00
IVF income_statement (quarterly, 2025-06-30) — Write Off: 1397353.00
IVF income_statement (quarterly, 2025-09-30) — +Operating Expense: 2264829.00
IVF income_statement (quarterly, 2025-09-30) — +Total Revenue: 1757094.00
IVF balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2391222.00
IVF balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 274200.00
IVF balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -428552.00
IVF balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 90063124.00
IVF cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 105350.00
IVF cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 105350.00
IVF cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
IVF balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
IVF income_statement (quarterly, 2025-09-30) — Basic Average Shares: 86190.00
IVF income_statement (quarterly, 2025-09-30) — Basic EPS: -30.80
IVF cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 549181.00
IVF cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -8062.00
IVF balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2252929.00
IVF balance_sheet (quarterly, 2025-09-30) — Capital Stock: 8877901.00
IVF balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 355891.00
IVF balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 355891.00
IVF balance_sheet (quarterly, 2025-09-30) — Cash Financial: 355891.00
IVF cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 1591309.00
IVF cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -8062.00
IVF cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1776537.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 245194.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -33471.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Interest Payable: -10734.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Inventory: 20849.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 1887.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -114443.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Payable: 245194.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 211723.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 80354.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Receivables: -31945.00
IVF cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 168425.00
IVF cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -31945.00
IVF cash_flow (quarterly, 2025-09-30) — Changes In Cash: -193290.00
IVF balance_sheet (quarterly, 2025-09-30) — Common Stock: 542.00
IVF balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -3028637.00
IVF cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
IVF income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1127749.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Assets: 1136805.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 265808.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Debt: 1029293.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1295101.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 720407.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 720407.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 9244687.00
IVF balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 880000.00
IVF cash_flow (quarterly, 2025-09-30) — Depreciation: 31391.00
IVF cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 136741.00
IVF income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 136741.00
IVF cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 136741.00
IVF income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 136741.00
IVF income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 86190.00
IVF income_statement (quarterly, 2025-09-30) — Diluted EPS: -30.80
IVF income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2644625.00
IVF income_statement (quarterly, 2025-09-30) — EBIT: -2498822.00
IVF income_statement (quarterly, 2025-09-30) — EBITDA: -2362081.00
IVF income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 12827.00
IVF cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -12827.00
IVF cash_flow (quarterly, 2025-09-30) — End Cash Position: 355891.00
IVF cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 1591309.00
IVF balance_sheet (quarterly, 2025-09-30) — Finished Goods: 138148.00
IVF cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -1784599.00
IVF income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: 0.00
IVF balance_sheet (quarterly, 2025-09-30) — Goodwill: 5878986.00
IVF balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 7309481.00
IVF balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2930708.00
IVF income_statement (quarterly, 2025-09-30) — Gross Profit: 629345.00
IVF income_statement (quarterly, 2025-09-30) — Interest Expense: 145803.00
IVF income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 145803.00
IVF cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 87849.00
IVF balance_sheet (quarterly, 2025-09-30) — Inventory: 191762.00
IVF balance_sheet (quarterly, 2025-09-30) — Invested Capital: -1047676.00
IVF cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -8062.00
IVF balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 3080581.00
IVF balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 613771.00
IVF balance_sheet (quarterly, 2025-09-30) — Investmentsin Subsidiariesat Cost: 2466810.00
IVF cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 1650000.00
IVF cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
IVF balance_sheet (quarterly, 2025-09-30) — Leases: 96817.00
IVF balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1987121.00
IVF balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 951668.00
IVF balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2938789.00
IVF balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 3080581.00
IVF balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 89904.00
IVF cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
IVF cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
IVF balance_sheet (quarterly, 2025-09-30) — Net Debt: 1625070.00
IVF income_statement (quarterly, 2025-09-30) — Net Income: -2644625.00
IVF income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2644625.00
IVF income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2644625.00
IVF income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
IVF income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2644625.00
IVF income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2644625.00
IVF cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2644625.00
IVF income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2644625.00
IVF income_statement (quarterly, 2025-09-30) — Net Interest Income: -145803.00
IVF cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -78257.00
IVF income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -145803.00
IVF balance_sheet (quarterly, 2025-09-30) — Net PPE: 2502156.00
IVF cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -8062.00
IVF cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 1650000.00
IVF balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -1460759.00
IVF balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 4803175.00
IVF income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1485916.00
IVF income_statement (quarterly, 2025-09-30) — Normalized Income: -1768460.00
IVF cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1776537.00
IVF cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 863338.00
IVF income_statement (quarterly, 2025-09-30) — Operating Income: -1635484.00
IVF income_statement (quarterly, 2025-09-30) — Operating Revenue: 1757094.00
IVF balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 135595.00
IVF balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 314952.00
IVF balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 149293.00
IVF balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 10500.00
IVF income_statement (quarterly, 2025-09-30) — Other Income Expense: -863338.00
IVF balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1430495.00
IVF cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -793764.00
IVF balance_sheet (quarterly, 2025-09-30) — Other Payable: 4484500.00
IVF balance_sheet (quarterly, 2025-09-30) — Other Properties: 2743987.00
IVF income_statement (quarterly, 2025-09-30) — Other Special Charges: 876165.00
IVF balance_sheet (quarterly, 2025-09-30) — Payables: 6875722.00
IVF balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 6875722.00
IVF balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 342957.00
IVF balance_sheet (quarterly, 2025-09-30) — Preferred Securities Outside Stock Equity: 0.00
IVF balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 8877359.00
IVF balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 8877359.00
IVF cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 1650000.00
IVF cash_flow (quarterly, 2025-09-30) — Preferred Stock Payments: 0.00
IVF income_statement (quarterly, 2025-09-30) — Pretax Income: -2644625.00
IVF cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 19566.00
IVF balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
IVF cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
IVF cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -8062.00
IVF balance_sheet (quarterly, 2025-09-30) — Raw Materials: 53614.00
IVF balance_sheet (quarterly, 2025-09-30) — Receivables: 274200.00
IVF income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1127749.00
IVF income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 136741.00
IVF cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -78257.00
IVF cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
IVF income_statement (quarterly, 2025-09-30) — Research And Development: 0.00
IVF balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -93092303.00
IVF cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
IVF income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2128088.00
IVF balance_sheet (quarterly, 2025-09-30) — Share Issued: 135595.00
IVF income_statement (quarterly, 2025-09-30) — Special Income Charges: -876165.00
IVF cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 493348.00
IVF balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5848722.00
IVF balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -10338118.00
IVF income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IVF income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
IVF income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
IVF balance_sheet (quarterly, 2025-09-30) — Total Assets: 18832198.00
IVF balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 6800390.00
IVF balance_sheet (quarterly, 2025-09-30) — Total Debt: 4233890.00
IVF balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5848722.00
IVF income_statement (quarterly, 2025-09-30) — Total Expenses: 3392578.00